Optimizing Bispecific Use Through EMR Utilization

EP: 1.Conditions for Administering Bispecific Therapy

EP: 2.Navigating Barriers Which Inhibit Optimal Use of Bispecifics

EP: 3.Key Decision Makers and Contributors Involved In Bispecific Administration

EP: 4.Pain Points In Bispecific Operationalization

EP: 5.Risk Evaluation and Mitigation Strategies [REMS] Program Considerations For Bispecific Therapy

Now Viewing

EP: 6.Optimizing Bispecific Use Through EMR Utilization

EP: 7.Best Practices For Uptake and Use of Bispecific Therapy

EP: 8.Achieving Seamless Care Transitions With Patients Receiving Bispecific Therapy

EP: 9.Intro to Bispecific Therapy: Implementation Essentials for Novice Institutions

EP: 10.Key Elements In Monitoring for Potential Adverse Events with Bispecific Antibodies

EP: 11.Protocol For Urgent and Around-the-Clock Bispecific Care

EP: 12.Obstacles to Optimal Transitions of Care Between Academic and Community Settings When Utilizing Bispecific Antibodies

EP: 13.Managed Care Considerations Within Bispecific Landscape

EP: 14.Payor-Provider Collaboration Driving Optimal Bispecific Therapy Strategies

EP: 15.Medication Assistance Programs Mitigating Financial Burden For Patients Receiving Bispecific Therapy

EP: 16.Bispecific Therapies: Current and Future Considerations

The following is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA, CPEL; Kirollos Hanna, PharmD, BCPS, BCOP, FACCC; Sarah Rockwell, PharmD, BCOP; Melody Chang, RPh, MBA, BCOP; and Ryan Cain, PA-C.

In this video, medical experts discuss the critical role of electronic medical records (EMR) in the effective management of healthcare, particularly when employing bispecific antibodies for various hematologic malignancies. The success in their management is attributed to the presence of well-established EMR order sets and easily accessible information. Dr. Chang is asked about the role of EMR in their setting, and he highlights its importance in optimizing the utilization of bispecific antibodies.

The EMR serves as a centralized information hub, encompassing patient demographics, treatment plans, dosing schedules, and response assessments. Real-time data entry and updates enable clinicians to input information on patient responses, adverse events, and modifications to treatment plans directly into the EMR. This ensures that the entire care team has timely access to the latest information, promoting coordinated and informed decision-making. The EMR also incorporates billing functions and financial documentation, allowing financial staff to document insurance authorizations and other billing-related details.

Several features and functions are integrated into the EMR to enhance efficiency and ensure comprehensive care throughout the bispecific treatment journey. The speaker emphasizes the integration of protocols, standard operations, and training materials into the system, including management strategies for cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and the risk evaluation and mitigation strategy (REMS) program.

While acknowledging the benefits of EMR, the speaker recognizes that challenges exist, such as the need for thorough training to navigate the system efficiently. Additionally, ensuring the security and confidentiality of patient data is highlighted as crucial. Overall, the integration of bispecific-related information into the EMR system is credited with significantly contributing to operational success in healthcare delivery.

Video synopsis is AI-generated and reviewed by AJMC editorial staff.